Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021

SELL
$60.19 - $75.29 $270,493 - $338,353
-4,494 Closed
0 $0
Q2 2021

Aug 13, 2021

BUY
$62.12 - $74.2 $14,473 - $17,288
233 Added 5.47%
4,494 $330,000
Q1 2021

May 06, 2021

SELL
$57.98 - $73.08 $140,079 - $176,561
-2,416 Reduced 36.18%
4,261 $262,000
Q4 2020

Feb 12, 2021

BUY
$62.61 - $71.29 $418,046 - $476,003
6,677 New
6,677 $476,000
Q1 2020

May 14, 2020

SELL
$34.75 - $45.85 $197,102 - $260,061
-5,672 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$36.66 - $41.78 $207,935 - $236,976
5,672 New
5,672 $230,000

Others Institutions Holding RDY

About DR REDDYS LABORATORIES LTD


  • Ticker RDY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 166,028,992
  • Market Cap $2.56B
  • Description
  • Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...
More about RDY
Track This Portfolio

Track Blueshift Asset Management, LLC Portfolio

Follow Blueshift Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blueshift Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Blueshift Asset Management, LLC with notifications on news.